JMU team develops light-driven nanorobots for precise bacteria manipulation
Updated
Updated · SciTechDaily · Apr 26
JMU team develops light-driven nanorobots for precise bacteria manipulation
3 articles · Updated · SciTechDaily · Apr 26
Researchers at Julius-Maximilians-Universität Würzburg, led by Professor Bert Hecht, created nanorobots less than one micrometer in size that use photon recoil for propulsion and light polarization for steering.
These agile nanorobots can capture, transport, and release significant numbers of bacteria, enabling systematic cleaning and manipulation in microscopic environments, even while carrying larger bacterial clusters.
The breakthrough demonstrates how light can actively shape the microscopic world, offering new tools for microbiology, biomedical research, and precise manipulation of biological materials at extremely small scales.
Beyond 'cleaning,' can these nanorobots be programmed to hunt specific superbugs?
Can light-powered nanobots overcome the barrier of human tissue to fight disease?
Will DNA self-assembly soon allow for mass production of these microscopic robots?
How will scientists command an entire swarm of these nanorobots to work together?
What happens when billions of tiny metal robots are left inside a patient?
Breakthrough in Nanorobotics: Photon Recoil Propulsion Enables Submicron Bacteria Manipulation
Overview
In April 2026, Professor Bert Hecht and his team at JMU unveiled light-steered nanorobots that use plasmonic nanoantennas to absorb and re-emit light, generating photon recoil forces for propulsion at speeds up to 50 micrometers per second. By adjusting light polarization, they achieve precise steering and can capture bacteria using optical trapping and thermophoretic forces, transporting loads hundreds of times their weight without damage. These capabilities enable applications in microbiology, environmental cleanup, and biomedicine. However, challenges like expensive fabrication, limited deep-tissue operation, and long-term biocompatibility must be overcome before clinical use, with ongoing research exploring scalable production and coordinated swarm control.